NumFin

Berry Genomics Co.,Ltd

Symbol: 000710.SZ

SHZ

9.49

CNY

Market price today

  • -7.7234

    P/E Ratio

  • 0.0509

    PEG Ratio

  • 3.34B

    MRK Cap

  • 0.00%

    DIV Yield

Berry Genomics Co.,Ltd (000710-SZ) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Berry Genomics Co.,Ltd (000710.SZ). Companys revenue shows the average of 470.194 M which is 0.141 % gowth. The average gross profit for the whole period is 190.098 M which is 1.036 %. The average gross profit ratio is 0.248 %. The net income growth for the company last year performance is 0.694 % which equals -1.183 % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Berry Genomics Co.,Ltd, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.144. In the realm of current assets, 000710.SZ clocks in at 1472.997 in the reporting currency. A significant portion of these assets, precisely 352.008, is held in cash and short-term investments. This segment shows a change of 0.041% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 34.59, if any, in the reporting currency. This indicates a difference of -74.138% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 45.686 in the reporting currency. This figure signifies a year_over_year change of -0.128%. Shareholder value, as depicted by the total shareholder equity, is valued at 1864.035 in the reporting currency. The year over year change in this aspect is -0.190%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 828.461, with an inventory valuation of 229.3, and goodwill valued at 13.43, if any. The total intangible assets, if present, are valued at 90.53.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

1232.03352338.1421.7
633.1
417.9
423.6
411.6
74
67
101.6
101.2
86.7
69.5
101.3
64.2
78.5
4.9
6.9
11.1
35.3
43.8
26.7
22
34
17
19.2
26.7
7.6
9.8
15.4

balance-sheet.row.short-term-investments

34.513.94.53.8
3.8
6.4
84.9
-14.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
5
0
0
0

balance-sheet.row.net-receivables

3941.76828.51111.81156.3
1142.3
893.7
682
559.7
121.1
98
114.1
91.9
90.8
135.7
135.6
167.3
88.5
106.9
115
96
91.1
81.6
49.4
179.9
11.2
32.3
31.9
23.9
0.7
6.9
4.7

balance-sheet.row.inventory

908.64229.3230.9233.9
180.3
421.9
205.7
107.5
53.4
50.7
51.5
47.6
48.4
49
43.8
34.6
36.2
36.9
39.9
45.5
49.8
26.5
23
41.3
56.3
54.7
52.3
60
56.1
43.6
28.7

balance-sheet.row.other-current-assets

250.2863.24694.7
52.3
119.1
45.9
23.8
1.1
0
-2.1
-1.1
-1.8
-1.7
-2.2
-7.4
-4.9
-18.5
-14
-14.2
-10.8
-19.9
0.3
-9.5
101.5
86.8
108.7
85
52.6
31.7
23

balance-sheet.row.total-current-assets

6332.7114731726.91906.6
2008
1852.6
1357.2
1102.7
249.6
215.8
265.1
239.6
224
252.5
278.4
258.7
198.4
130.3
147.7
138.3
165.5
132
99.4
233.7
202.9
190.8
212.1
195.6
117.1
91.9
71.7

balance-sheet.row.property-plant-equipment-net

3993.92923.41100.81130.7
909.3
811
585.1
538.2
143.4
145.2
72.9
82.2
80.3
80.9
83
83.5
89.3
88.9
96.4
94.9
102.4
115.3
124.3
121.1
126.5
104.4
88
92
77.9
42.5
26.1

balance-sheet.row.goodwill

53.7313.413.413.4
13.4
13.4
13.4
13.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

356.4490.577.574
70.7
85.2
81.6
16
15.5
15.8
16.2
33.1
31.3
16.7
16.8
16.8
16.9
0.4
0.5
0.6
0.6
1.1
0.7
1.8
2.2
2.5
0.9
1
2
0
0

balance-sheet.row.goodwill-and-intangible-assets

410.1810490.987.5
84.1
98.7
95.1
29.5
15.5
15.8
16.2
33.1
31.3
16.7
16.8
16.8
16.9
0.4
0.5
0.6
0.6
1.1
0.7
1.8
2.2
2.5
0.9
1
2
0
0

balance-sheet.row.long-term-investments

258.9434.6133.8275.3
163.3
175.5
0
37.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5
0
0
0
0

balance-sheet.row.tax-assets

511.73151.3102.263.9
26.4
31.6
14
7.4
0
0
0
0
5.3
5.2
5.1
7
6.7
6.4
0
0
0
0
0
0
0
0
6
0
0
0
0

balance-sheet.row.other-non-current-assets

175.8854.946.355.8
52.8
99.4
126.7
91.1
139.6
122.1
91.6
55.1
0
0
0
0
0
0
0
0
10
10
17.7
0.7
0.8
1
5.7
1.4
2.1
2.1
2.6

balance-sheet.row.total-non-current-assets

5350.651268.214741613.1
1235.9
1216.3
820.8
703.7
298.5
283.1
180.7
170.5
117
102.7
104.9
107.3
112.9
95.7
96.9
95.5
113.1
126.4
142.7
123.6
129.4
107.9
95.6
94.3
82
44.6
28.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

11683.362741.23200.93519.7
3244
3068.9
2178
1806.4
548
498.9
445.9
410.1
341
355.2
383.3
366
311.3
226
244.6
233.8
278.5
258.4
242.1
357.3
332.4
298.7
307.8
289.9
199.1
136.5
100.4

balance-sheet.row.account-payables

1150.41292.5278.9339.9
243.3
213.3
82.8
86.8
186.4
144
145
136.9
110.4
139.4
168.9
129.6
92.9
41.4
38.2
34.3
32.3
26.2
23.2
23.8
36
32
32
41.2
40.5
20.5
10.2

balance-sheet.row.short-term-debt

992.54257.9216.7200
123.5
11.3
0
29.3
74.1
60.1
83.3
114.7
64.6
78.6
79
106.5
101.5
78.5
88.7
86.9
113.5
108.3
93.8
155.8
55
29.9
17.8
21.6
25.7
15.1
15

balance-sheet.row.tax-payables

90.7525.415.828.1
39.7
28.8
26.4
33.6
3.8
3.9
3.8
3.8
5
3.8
4.7
4.2
3.7
3.9
4.5
3.9
4.3
3.7
5.1
6.9
3.4
4.3
2.1
7.5
3
6.8
5

balance-sheet.row.long-term-debt-total

309.7345.7131.5199.3
236.3
244.8
0
0
33.5
34.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
12.1
24.9
46.9
42.5
22.4

Deferred Revenue Non Current

44.631112.13.7
4.8
10.1
10.3
7.8
114.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

94.08---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

117.079.3105.66.8
2.8
136.6
142.5
41.2
1.3
1.2
1
0.6
1
1.4
2
4.8
3.6
3.5
5.4
3.4
8.5
2.3
4.5
3.9
2.2
4.4
4.6
0.9
0.2
1.6
0.4

balance-sheet.row.total-non-current-liabilities

450.8883.5166.8227.4
265.1
272.1
10.3
7.8
148.2
125.8
23.1
0.8
0.7
0
0
0
0
0
0
0
0
0
0
0
10
0
12.1
24.9
46.9
42.5
22.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

16.883.54.913.6
24.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

3445.78846.6871.5996
821.5
721.8
235.7
245.9
434
381.2
315.8
289.1
217.3
232.7
261
251.5
206.9
131.5
144.9
135.3
165.8
146.3
133.2
195.8
125.3
77.8
96.3
104.3
125.1
95.4
61.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1416.25353.5354.6354.6
354.6
354.6
354.6
354.6
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
151.2
108
108
108
60
42.5
31.6
31.6

balance-sheet.row.retained-earnings

1660.45257684.2942
1052.9
866.7
524.4
275.3
-97.5
-93.4
-80.3
-87.2
-81.1
-81.5
-82
-90.2
-100.6
-103.7
-97.2
-98.4
-84.2
-84.8
-88
-37.2
39.6
53.8
45.7
25.6
4.2
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

3067.810485.6416.5
260.4
236.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

1969.571253.5777777
720.6
870.7
1024.5
906.6
60.4
59.8
59.2
51.5
47.9
47
47
47
47
47
45.8
45.8
45.7
45.7
45.7
45.2
55.9
55.5
54.1
96.3
23
9.6
7.5

balance-sheet.row.total-stockholders-equity

8114.0918642301.42490.2
2388.4
2328.4
1903.4
1536.6
114.1
117.7
130
115.4
118
116.7
116.2
108
97.5
94.5
99.8
98.6
112.8
112.1
108.9
159.3
203.5
217.4
207.8
182
69.7
41.1
39

balance-sheet.row.total-liabilities-and-stockholders-equity

11683.362741.23200.93519.7
3244
3068.9
2178
1806.4
548
498.9
445.9
410.1
341
355.2
383.3
366
311.3
226
244.6
233.8
278.5
258.4
242.1
357.3
332.4
298.7
307.8
289.9
199.1
136.5
100.4

balance-sheet.row.minority-interest

123.4930.627.933.5
34
18.7
38.9
23.9
0
0
0
5.6
5.6
5.8
6
6.5
6.8
0
0
0
0
0
0
2.2
3.5
3.5
3.6
3.6
4.2
0
0

balance-sheet.row.total-equity

8237.581894.62329.32523.7
2422.4
2347
1942.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

11683.36---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

293.4448.4138.3279.1
167.1
182
84.9
22.7
133.1
115.1
91.6
55.1
0
0
0
0
0
0
0
0
0
0
17.7
0.7
0.8
0.9
1
5
0
0
0

balance-sheet.row.total-debt

1304.71303.6348.2399.3
359.8
256.1
0
29.3
107.6
94.6
83.3
114.7
64.6
78.6
79
106.5
101.5
78.5
88.7
86.9
113.5
108.3
93.8
155.8
65
29.9
29.9
46.5
72.6
57.6
37.4

balance-sheet.row.net-debt

107.18-34.614.6-18.6
-269.5
-155.4
-423.6
-382.4
33.5
27.5
-18.3
13.5
-22
9.1
-22.3
42.3
22.9
73.6
81.7
75.8
78.2
64.5
67.1
133.8
31.1
12.9
16.7
24.8
65
47.8
22

Cash Flow Statement

The financial landscape of Berry Genomics Co.,Ltd has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 2.072. The company recently extended its share capital by issuing 0, marking a difference of -0.306 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -49418244.600 in the reporting currency. This is a shift of -0.858 from the previous year. In the same period, the company recorded 102.72, 1.96, and -339.28, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -17.58 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 275.56, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

-398.22-252.2-109.9205.7
387.1
259.8
244.4
-4.2
-13
6.8
-6.2
0.2
0.3
7.6
10.2
2.8
-12.7
1.2
-14.3
0.6
3.2
-50.8
-45.7
1.6
13.8
23.6

cash-flows.row.depreciation-and-amortization

91.48102.7106.476.9
82.9
67.5
54.3
5.4
6.8
6.6
6.5
6
7.6
7.6
7.5
7.5
7.3
8.6
8.5
9.4
9.8
9.6
9
8.1
4.4
3.6

cash-flows.row.deferred-income-tax

0-39.4-378.2
5.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

051.222.47
-5.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

72.85-145.2-77.4-160.8
-358.5
-221.9
-233.2
6.2
-41.3
37
18
36.9
-34.3
57.1
-32.5
39.6
2.5
-2
4.8
-19.9
-18.2
56.2
-70.1
-22.8
-5.8
-11.9

cash-flows.row.account-receivables

83.22-24.6-134.9-295.2
-221.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0.896.9-57.520.3
-216.1
-68.1
-25.6
-0.8
0.9
-6
0.4
0.7
-5.2
-9.1
0.1
0.2
1.9
5.6
3.8
-20.9
-3.5
20.2
3
-1.7
-2.4
4.3

cash-flows.row.account-payables

0-88152105.9
73.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-11.26-39.4-378.2
5.8
-153.7
-207.6
7
-42.1
43.1
17.6
36.2
-29.1
66.3
-32.6
39.3
0.6
-7.6
1
1
-14.7
35.9
-73.1
-21.2
-3.4
-16.3

cash-flows.row.other-non-cash-items

343.71304.2189.524.4
11.5
60
8.8
-21.7
-23.4
-31.5
-2.6
5.2
5
3.9
12.5
7.9
7.6
3.9
8.6
3.4
4
0
21.4
4.9
2.9
13

cash-flows.row.net-cash-provided-by-operating-activities

109.81000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-60.91-73.3-336.7-112.5
-295.3
-165.9
-204.8
-57.9
-62.5
-2.4
-7
-17.9
-6.2
-5.2
-2.7
-5.9
-0.4
-8.6
-0.7
-0.1
-1.5
0
0
-7
-22.3
-17.3

cash-flows.row.acquisitions-net

0.091.70.4190.4
-6.1
24.4
0
1288.4
0
39
0
0
0
-1.5
-1
-1
0
0
0
0
1.5
0
0
0
0
0

cash-flows.row.purchases-of-investments

00-35.7-53.3
-64
-31
-67.3
-1155.7
0
-21
-43.6
0
0
0
0
0
0
0
0
0
-10
-18
0
0
0
0

cash-flows.row.sales-maturities-of-investments

7.220.224.554.4
0.8
2.8
111.7
7.5
4.5
2
0
0
0
0
0
0
0
0
10.2
0.6
22.4
0
0
0
12.3
0

cash-flows.row.other-investing-activites

1.16200
-7.8
0.2
288.3
-57.9
68.8
21.8
0.9
0.2
0.2
0.1
0.4
0.5
0.9
0.1
0.1
7.2
-1.5
79.7
3.4
0.1
0.8
0

cash-flows.row.net-cash-used-for-investing-activites

-59.66-49.4-347.579
-372.4
-169.5
127.8
24.4
10.7
39.5
-49.7
-17.7
-6
-6.7
-3.3
-6.4
0.5
-8.4
9.7
7.7
10.9
61.7
3.4
-6.8
-9.2
-17.3

cash-flows.row.debt-repayment

-251.21-339.3-199-239.3
-22.6
-29.5
-8.5
-45
-79.5
-111
-50
-60
-95
-130
-91.5
-65.4
-65.1
-68.3
-106.3
-108.3
-92.3
-157
-55.4
-37.9
-25
-15.6

cash-flows.row.common-stock-issued

0056.3-150.1
10.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-56.3-150.1
-10.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-14.77-17.6-20.3-29.2
-8.4
-0.8
-0.9
-2.3
-4.1
-7.1
-6.4
-3.3
-4.1
-3.3
-6.2
-6.9
-4.4
-4.2
-5.4
-5.7
-7.2
-9.8
-20.9
-1.7
-2.7
-4.4

cash-flows.row.other-financing-activites

131.46275.6264.2553.2
266.9
43.4
31.3
46.4
115.4
87.8
71.6
59.4
98.7
44
84
94.4
62.4
65.1
70.3
104.3
106.8
95
146.2
71.5
25.4
0.5

cash-flows.row.net-cash-used-provided-by-financing-activities

-100.5-81.344.8-15.6
235.9
13.2
21.9
-1
31.9
-30.3
15.1
-3.9
-0.3
-89.3
-13.7
22.1
-7.1
-7.4
-41.4
-9.7
7.3
-71.8
70
32
-2.3
-19.5

cash-flows.row.effect-of-forex-changes-on-cash

2.5311.2-2.7-6.7
-0.3
3
1.6
0.1
0.1
0
0.1
0
-0.3
-0.1
-0.1
0
-0.1
-0.1
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-11.61-98.3-211.3218
-13.7
12
225.6
9.3
-28.1
28.1
-18.8
26.6
-28.1
-19.9
-19.3
73.6
-2
-4.2
-24.2
-8.5
17
4.8
-12
16.9
3.8
-8.5

cash-flows.row.cash-at-end-of-period

1158.27318.3416.6627.9
409.9
423.6
411.6
28.4
19
47.1
19
37.8
11.2
39.3
59.2
78.5
4.9
6.9
11.1
35.3
43.8
26.7
22
34
17
13.2

cash-flows.row.cash-at-beginning-of-period

1169.88416.6627.9409.9
423.6
411.6
186
19
47.1
19
37.8
11.2
39.3
59.2
78.5
4.9
6.9
11.1
35.3
43.8
26.7
21.9
34
17
13.2
21.7

cash-flows.row.operating-cash-flow

109.8121.294161.3
123.1
165.3
74.4
-14.2
-70.8
18.9
15.6
48.3
-21.5
76.2
-2.3
57.8
4.7
11.7
7.6
-6.4
-1.2
14.9
-85.4
-8.2
15.3
28.3

cash-flows.row.capital-expenditure

-60.91-73.3-336.7-112.5
-295.3
-165.9
-204.8
-57.9
-62.5
-2.4
-7
-17.9
-6.2
-5.2
-2.7
-5.9
-0.4
-8.6
-0.7
-0.1
-1.5
0
0
-7
-22.3
-17.3

cash-flows.row.free-cash-flow

48.9-52.1-242.748.8
-172.2
-0.5
-130.5
-72.1
-133.3
16.5
8.6
30.4
-27.6
71
-5
51.9
4.3
3.1
6.9
-6.6
-2.7
14.9
-85.4
-15.2
-7
11

Income Statement Row

Berry Genomics Co.,Ltd's revenue saw a change of -0.158% compared with the previous period. The gross profit of 000710.SZ is reported to be 515.2. The company's operating expenses are 545.15, showing a change of -10.279% from the last year. The expenses for depreciation and amortization are 102.72, which is a -3.921% change from the last accounting period. Operating expenses are reported to be 545.15, which shows a -10.279% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -18.391% year-over-year growth. The operating income is -450.74, which shows a 18.391% change when compared to the previous year. The change in the net income is 0.694%. The net income for the last year was -427.2.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

income-statement-row.row.total-revenue

1148.741151.413681422.2
1540.4
1617.6
1439.8
1171.2
247.4
230.1
273.6
262.2
331.1
409.7
464.2
409
286.9
180.6
148.7
130.6
119.7
81.3
62.6
51.1
79.3
99.8
118.4
113.1
112.8
107.1
76.2

income-statement-row.row.cost-of-revenue

614.52636.2783.6786
729.8
628.8
601.3
455.3
230.6
221.7
255.4
229.4
289.3
368.7
408.9
353.8
256.9
167.1
127.4
115.2
100.1
65.7
57.2
58.7
58.6
72.2
77.3
72.8
74.8
71
49.1

income-statement-row.row.gross-profit

534.22515.2584.4636.2
810.6
988.8
838.5
715.9
16.7
8.4
18.3
32.8
41.7
41
55.2
55.2
29.9
13.5
21.3
15.3
19.6
15.6
5.4
-7.6
20.7
27.6
41.1
40.3
38
36.1
27.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

110.03---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

26.94---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

279.09---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-3.03-2.7173.7134.5
102.1
88.1
86.1
9.1
52
0.2
0.4
0
0.6
1
0.9
1.4
4
2.9
5.1
3.2
6.9
5.9
4.4
0.1
1
2.1
2.5
5.2
2
1.3
1.2

income-statement-row.row.operating-expenses

544.91545.2607.6620.1
553.7
536.6
481.7
437.2
44
44.8
42.7
37.2
37.4
35.8
41
34.9
24.8
19.3
20.5
27.6
20.5
15.8
51.9
34
17.8
12.2
13.1
15.1
15.4
14
9.2

income-statement-row.row.cost-and-expenses

1159.431181.41391.31406
1283.5
1165.4
1083
892.5
274.6
266.5
298.1
266.6
326.7
404.5
450
388.7
281.7
186.4
147.9
142.8
120.6
81.5
109.1
92.7
76.3
84.4
90.4
87.8
90.2
84.9
58.3

income-statement-row.row.interest-income

4.542.62.45.1
2.7
2.1
2.9
2.4
0.7
1.7
1.9
1.8
1.9
1.6
0.4
1.2
1.8
0.1
0.1
0.4
0.1
0.3
1.2
4
1.7
0
0
0
0
0
0

income-statement-row.row.interest-expense

10.8616.417.620.3
15.3
0.1
0.9
0.9
3.5
4.1
7.1
6.4
3.3
4.1
3.3
6.2
6.9
4.4
4.6
5.7
5.8
7.1
9.9
8
3.1
2.2
4.7
1.8
2.3
1.3
0.7

income-statement-row.row.selling-and-marketing-expenses

279.09---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-9.9-2.7-260-81.6
0.2
-4.5
5.9
5.5
23.1
23.4
31.2
3.5
-3.4
-4.2
-3.8
-10.4
-2.8
-5.8
-3.8
-3.4
-0.8
-1
-4.9
-5.3
-2.4
-1.1
-3.6
1.2
-2.3
-1.3
-0.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-3.03-2.7173.7134.5
102.1
88.1
86.1
9.1
52
0.2
0.4
0
0.6
1
0.9
1.4
4
2.9
5.1
3.2
6.9
5.9
4.4
0.1
1
2.1
2.5
5.2
2
1.3
1.2

income-statement-row.row.total-operating-expenses

-9.9-2.7-260-81.6
0.2
-4.5
5.9
5.5
23.1
23.4
31.2
3.5
-3.4
-4.2
-3.8
-10.4
-2.8
-5.8
-3.8
-3.4
-0.8
-1
-4.9
-5.3
-2.4
-1.1
-3.6
1.2
-2.3
-1.3
-0.6

income-statement-row.row.interest-expense

10.8616.417.620.3
15.3
0.1
0.9
0.9
3.5
4.1
7.1
6.4
3.3
4.1
3.3
6.2
6.9
4.4
4.6
5.7
5.8
7.1
9.9
8
3.1
2.2
4.7
1.8
2.3
1.3
0.7

income-statement-row.row.depreciation-and-amortization

375.15113.9-39106.4
131
96.3
86.7
54.3
5.4
6.8
6.6
6.5
6
7.6
7.6
7.5
7.5
7.3
8.6
8.5
9.4
9.8
9.6
9
8.1
4.4
3.6
-1.1
0.2
0
-0.4

income-statement-row.row.ebitda-caps

-37.06---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-412.21-450.7-23.2-38.8
245.2
450.2
305.1
275.1
-7.9
-13
6.4
-0.9
0.4
-0.1
9.5
8.5
-1.6
-14.2
0.3
-16.1
-3.8
1.7
-54.6
-44.5
3.3
16.2
27
26.3
22.4
22.2
18.3

income-statement-row.row.income-before-tax

-422.11-453.4-283.3-120.4
245.3
445.7
310.9
284.2
-4.2
-13
6.8
-0.9
0.9
0.9
10.4
9.9
2.4
-11.7
1.2
-14.3
0.6
3.2
-50.8
-45.7
2.4
16.3
27
29
22.4
22.2
18.4

income-statement-row.row.income-tax-expense

-26.37-28.2-31-10.5
39.7
58.5
51.2
39.8
77
28.1
41.5
5.3
0.7
0.6
2.8
-0.3
-0.4
1
0.8
2.4
4.9
6.1
5
1.3
0.8
2.5
3.3
3.8
6.6
7.3
6.1

income-statement-row.row.net-income

-398.22-427.2-252.2-109.9
210.7
390.6
268.1
232.7
-4.2
-13
6.9
-6.2
0.4
0.5
8.1
10.5
2.8
-12.7
1.2
-14.3
0.6
3.2
-50.8
-44.3
1.6
13.8
23.6
25.2
15.8
14.8
12.3
Similar Stocks
You may also be interested in:
SRNE
Sorrento Therapeutics, Inc..
0.015 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
8.42 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.0361 USD
NASDAQ
GUBRA.CO
Gubra A/S.
303 DKK
CPH
T5O.DE
CytoTools AG.
0.486 EUR
XETRA
HBC.OL
Hofseth BioCare ASA.
2.03 NOK
OSL
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
41.5 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ

Frequently Asked Question

What is Berry Genomics Co.,Ltd (000710.SZ) total assets?

Berry Genomics Co.,Ltd (000710.SZ) total assets is 2741165147.000.

What is enterprise annual revenue?

The annual revenue is 563342266.000.

What is firm profit margin?

Firm profit margin is 0.465.

What is company free cash flow?

The free cash flow is -0.157.

What is enterprise net profit margin?

The net profit margin is -0.347.

What is firm total revenue?

The total revenue is -0.359.

What is Berry Genomics Co.,Ltd (000710.SZ) net profit (net income)?

The net profit (net income) is -427196505.920.

What is firm total debt?

The total debt is 303579022.000.

What is operating expences number?

The operating expences are 545150751.000.

What is company cash figure?

Enretprise cash is 246677815.000.